Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PANACEA BIOTECH - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PANACEA BIOTECH BIOCON /
PANACEA BIOTECH
 
P/E (TTM) x 35.2 9.5 369.3% View Chart
P/BV x 4.5 3.7 120.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON    PANACEA BIOTECH
EQUITY SHARE DATA
    BIOCON
Mar-19
PANACEA BIOTECH
Mar-19
BIOCON /
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs707354 200.0%   
Low Rs554138 400.7%   
Sales per share (Unadj.) Rs91.974.6 123.3%  
Earnings per share (Unadj.) Rs16.76.7 250.2%  
Cash flow per share (Unadj.) Rs24.215.5 156.0%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.657.2 177.7%  
Shares outstanding (eoy) m600.0061.25 979.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.93.3 208.0%   
Avg P/E ratio x37.736.8 102.5%  
P/CF ratio (eoy) x26.115.9 164.4%  
Price / Book Value ratio x6.24.3 144.3%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33015,061 2,511.9%   
No. of employees `0006.12.3 265.0%   
Total wages/salary Rs m11,6531,471 792.3%   
Avg. sales/employee Rs Th8,994.31,973.6 455.7%   
Avg. wages/employee Rs Th1,900.7635.6 299.0%   
Avg. net profit/employee Rs Th1,635.3176.8 925.0%   
INCOME DATA
Net Sales Rs m55,1444,567 1,207.4%  
Other income Rs m1,44445 3,223.2%   
Total revenues Rs m56,5884,612 1,227.0%   
Gross profit Rs m15,8832,030 782.5%  
Depreciation Rs m4,478540 829.3%   
Interest Rs m7091,048 67.6%   
Profit before tax Rs m12,140486 2,496.9%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,12377 2,753.6%   
Profit after tax Rs m10,026409 2,450.7%  
Gross profit margin %28.844.4 64.8%  
Effective tax rate %17.515.9 110.3%   
Net profit margin %18.29.0 203.0%  
BALANCE SHEET DATA
Current assets Rs m48,2282,415 1,997.4%   
Current liabilities Rs m30,3769,077 334.6%   
Net working cap to sales %32.4-145.9 -22.2%  
Current ratio x1.60.3 596.9%  
Inventory Days Days6865 104.9%  
Debtors Days Days8671 120.6%  
Net fixed assets Rs m64,1308,333 769.6%   
Share capital Rs m3,00061 4,894.0%   
"Free" reserves Rs m57,9803,443 1,684.1%   
Net worth Rs m60,9803,504 1,740.3%   
Long term debt Rs m15,766461 3,418.5%   
Total assets Rs m121,92413,755 886.4%  
Interest coverage x18.11.5 1,238.1%   
Debt to equity ratio x0.30.1 196.4%  
Sales to assets ratio x0.50.3 136.2%   
Return on assets %8.810.6 83.1%  
Return on equity %16.411.7 140.8%  
Return on capital %16.838.7 43.3%  
Exports to sales %28.120.9 134.6%   
Imports to sales %18.98.1 231.6%   
Exports (fob) Rs m15,506954 1,625.5%   
Imports (cif) Rs m10,399372 2,796.0%   
Fx inflow Rs m15,5061,203 1,288.9%   
Fx outflow Rs m10,399467 2,228.4%   
Net fx Rs m5,107736 693.5%   
CASH FLOW
From Operations Rs m11,5461,049 1,100.9%  
From Investments Rs m-7,138-54 13,342.1%  
From Financial Activity Rs m-2,417-1,011 239.0%  
Net Cashflow Rs m2,103-20 -10,675.1%  

Share Holding

Indian Promoters % 40.4 74.5 54.2%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.6 1,400.0%  
FIIs % 10.7 1.3 823.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 23.6 84.3%  
Shareholders   109,995 10,259 1,072.2%  
Pledged promoter(s) holding % 0.0 35.1 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CADILA HEALTHCARE  TTK HEALTHCARE  NEULAND LABS  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 450 Points in Opening Trade; Mindtree Up 5% Post Q3 Results(09:30 am)

Asian share markets and US stock futures are trading higher today as investors awaited comments from Joe Biden's Treasury Secretary nominee Janet Yellen on US stimulus and the dollar.

Related Views on News

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jan 19, 2021 10:32 AM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS